HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Featured Stories

From Probiotics To Prebiotics, Postbiotics and Synbiotics – The IPA Expands Its Scope

The International Probiotics Association has expanded its remit to include prebiotics, postbiotics and synbiotics – combinations of pre- and probiotics. HBW Insight asks the IPA's executive director George Paraskevakos what this means for the consumer healthcare industry and what the future of the microbiome-based wellness market might hold. 

International Wellness Biologics

CIR Expert Panel To Prioritize Cannabidiol Review In 2024 At FDA’s Request

Cosmetic Ingredients Cannabidiol CBD Safety

US OTC Nasal Product Firm Warned One Size Doesn’t Fit All Products For GMP Compliance

Latest Articles

Latest from PR Newswire

Click here to access further cosmetics and dietary supplement news.

Health Explore this Topic

Set Alert for Health

Latest From Health

Over The Counter 20 March 2023: The Shape Of The Global OTC Market To Come, With IQVIA Consumer Health's Amit Shukla

In this episode, HBW Insight catches up with IQVIA Consumer Health’s vice president of global consulting services, Amit Shukla, to find out how the global consumer healthcare market is performing as it comes out of the pandemic. It’s good news, Shukla reveals, based on the firm’s latest intelligence. The market grew double digits in 2022 and is predicted to expand by 5-6% per year in the future - even faster if some of the innovative switches currently in the pipeline succeed. Shukla points to artificial intelligence, sustainability and popular wellness ingredients as trends to watch that will drive future market growth.

Health International

Health And Wellness Weekly Trademarks Review: 14 March

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

OTC Drugs Trademarks

P&G Looks To Change Children’s Toothpaste Market With Crest Kids Color Changing

Color of the toothpaste, which P&G North America oral care chief says is “only one of its kind on the market today,” changes from blue to pink after two minutes of brushing.

Launches OTC Drugs

Futura Launches Eroxon Erectile Dysfunction Gel In Europe, US Launch Delayed Until Q2 2023

European consumers can now buy Futura Medical's Eroxon erectile dysfunction gel without a prescription online, and in person via Belgian pharmacies. Further country launches, supported by advertising and promotional campaigns, remain on track during the coming months, Futura says. However, the US launch, expected for Q1 this year, has been delayed while the firm answers questions posed by the FDA.

Europe Health

US Still Rinsing Out OTC Sanitizer Warnings

Of GMP warnings for OTC hand sanitizers, 114 have been submitted by FDA since pandemic began, with first sent in late April 2020, and another 12 for false COVID-19 claims, with first sent on 1 April. One GMP warning for hand sanitizer product is listed in both 2018 and 2019.

Coronavirus COVID-19 FDA

People On The Move: CHPNZ, Shop Apotheke, NutriLeads

A round-up of consumer health executive moves outside the US, including management changes at Consumer Health Products New Zealand, Shop Apotheke Europe and NutriLeads.

Europe International
See All

Beauty Explore this Topic

Set Alert for Beauty

Latest From Beauty

P&G Looks To Change Children’s Toothpaste Market With Crest Kids Color Changing

Color of the toothpaste, which P&G North America oral care chief says is “only one of its kind on the market today,” changes from blue to pink after two minutes of brushing.

Launches OTC Drugs

CIR Panel’s ‘Ethereal’ Role In Cosmetics Regulation Not Clarified By MoCRA

While other legislative proposals to update US cosmetics regulations would have included FDA ingredient review or codified reviews from the CIR Expert Panel for Cosmetic Ingredient Safety, the Modernization of Cosmetic Regulations Act of 2022 does not. Panelists, industry and FDA reps discussed implications for CIR at the 5-6 March meeting of the group’s independent expert panel.

Legislation Cosmetic Ingredients

Cosmetic And Personal Care Weekly Trademarks Review: 14 March

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Cosmetics Launches

CIR Expert Panel Hastens Review Of Propolis Extract; Other Highlights From 164th Meeting

Cosmetic Ingredient Review’s independent expert panel finalized assessments of seven ingredients at the 6-7 March meeting, advanced two tentative safety assessments, and issued three insufficient data announcements. Propolis extract was added to the group’s 2023 priorities list while 2024 priorities remain open to public comment.

Cosmetic Ingredients Safety

MoCRA Check-In: EAS Consulting's John Bailey On Proposed Cosmetics Office Move

John Bailey, independent advisor for colors and cosmetics at EAS Consulting Group and former director of the US FDA's cosmetics office, is checking in with HBW Insight periodically in 2023 to offer his views on developments under the Modernization of Cosmetic Regulations Act of 2022. Here he discusses the FDA's plan to move cosmetics regulation out of CFSAN and into the Office of the Chief Scientist.

FDA Regulation

Resilience, ‘Lessons Learned’ Must Be COVID Legacy In Germany

COVID-19 threat is abating and control measures easing, but government commitments made at height of pandemic to forearm against future health care emergencies should not be abandoned, says German Advisory Council on Health and Care and the IVD industry.

Consumer Coronavirus COVID-19
See All

Wellness Explore this Topic

Set Alert for Wellness

Latest From Wellness

ChromaDex Rides Nestle Deal To 14% Q4 Growth; Mannatech, USANA End Year In Slumps

ChromaDex reports Niagen ingredient sales growth propelled by upfront minimum purchase from Nestlé Health Science; and Mannatech and USANA both reported larger full-year sales dips after ending 2022 in slumps.

Dietary Supplements Sales & Earnings

Bill Steering Hemp In Supplements To NDI Notification Pathway Introduced For Third Time

Virginia Republican Morgan Griffith has same message for FDA he’s previously stated about hemp ingredients. Agency “has dragged its feet in properly regulating CBD and hemp-derived products on the market, creating confusion about its legal uses,” he says.

Cannabidiol CBD FDA

Health And Wellness Weekly Trademarks Review: 14 March

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

OTC Drugs Trademarks

Immunity Claims Cross The Line In Banned UK TikTok Ad

Claiming in a TikTok post that its Recover dietary supplement can help your immune system fight back” against an unspecified virus landed UK-based Tonic Health in hot water with the country's advertising regulator.

Ad Complaints Dietary Supplements

‘Unlawful Marketing’ Doesn't Establish Dietary Ingredients' Use Before Drug Approval Or Study

FDA explains thinking in a letter to Inner Mongolia Kingdomway Pharmaceutical after rejecting Chinese firm’s NDI notification for N-acetyl-L-cystein. Prior to its investigation as a drug, NMN wasn’t used in supplements available in US, “except unlawfully without an NDI notification.”

Dietary Supplements FDA

Petition To US FDA For Using NMN In Supplements Reminds Agency Of Its Reversal On NAC

Natural Products Association and Alliance for Natural Health USA petition FDA to reconsider its stance on beta-nicotinamide mononucleotide. Excluding NMN from use in supplements “adversely affects the entire dietary supplement stakeholder community,” petition says.

Dietary Supplements FDA
See All

Market Intelligence Explore this Topic

Set Alert for Market Intelligence

Latest From Market Intelligence

Over The Counter 20 March 2023: The Shape Of The Global OTC Market To Come, With IQVIA Consumer Health's Amit Shukla

In this episode, HBW Insight catches up with IQVIA Consumer Health’s vice president of global consulting services, Amit Shukla, to find out how the global consumer healthcare market is performing as it comes out of the pandemic. It’s good news, Shukla reveals, based on the firm’s latest intelligence. The market grew double digits in 2022 and is predicted to expand by 5-6% per year in the future - even faster if some of the innovative switches currently in the pipeline succeed. Shukla points to artificial intelligence, sustainability and popular wellness ingredients as trends to watch that will drive future market growth.

Health International

UK Cialis Rx-To-OTC Switch World-First For Sanofi, H2 2023 Launch Planned

The UK is the first country to allow OTC access to Sanofi's tadalafil-based erectile dysfunction drug Cialis following a successful switch. Approved as a pharmacy medicine, Sanofi will launch Cialis Together in the second half of the year. Cialis will compete against Viatris' sildenafil-based Viagra Connect in the men's sexual health and wellness category, which has seen a proliferation of products in recent months.

United Kingdom Health

CBD For Smoking Cessation? Study Shows Possible Benefits For Curbing Tobacco Use

A metabolite of CBD inhibits a key enzyme for nicotine metabolism, US researchers have found, potentially allowing nicotine users to wait before feeling the need to inhale more cigarette smoke. CBD shows promise, therefore, as a smoking cessation therapy, the study suggests. 

US States Health
See All
UsernamePublicRestriction

Register